Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Der Internist|February 2, 2013
[Personalized therapy concepts for malignant melanoma]M Schlaak, N Kreuzberg, C Mauch, et al.Case Reports in Dermatology|May 2, 2012
Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with BexaroteneX Zhang, M Schlaak, M Fabri, et al.The British Journal of Dermatology|February 1, 2007
Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progressionP Kurschat, S Eming, D Nashan, et al.The Journal of Biological Chemistry|July 20, 1999
Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell linesP Kurschat, P Zigrino, R Nischt, et al.The British Journal of Dermatology|March 27, 2013
Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patientsM Schlaak, A Bajah, T Podewski, et al.Archives of Dermatological Research|August 26, 1998
Regulation of connective tissue turnover by cell-matrix interactionsC MauchDTW. Deutsche Tierarztliche Wochenschrift|June 3, 2004
The influence of prepartal bacteriuria on the reproductive performance of the sowC Mauch, G BilkeiRheumatic Diseases Clinics of North America|February 1, 1990
Fibroblast-matrix interactions and their role in the pathogenesis of fibrosisC Mauch, T KreigDermatology Online Journal|September 10, 2005
Keratoacanthoma centrifugum marginatum accompanied by extensive granulomatous foreign body reactionP Kurschat, S Hess, N Hunzelmann, et al.Pageof 9